Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
| Actual shortage: | 231 (8%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2784 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2022-02-11 | 2022-02-22 | 154759 |
| APO-IBUPROFEN | 200MG | TABLET | Resolved | 2022-02-11 | 2022-05-14 | 154762 |
| APO-PROPAFENONE | 150MG | TABLET | Resolved | 2022-02-11 | 2022-03-25 | 154765 |
| APO-SIMVASTATIN | 10MG | TABLET | Resolved | 2022-02-11 | 2022-03-25 | 154770 |
| APO-AMLODIPINE-ATORVASTATIN | 20MG 10MG | TABLET | Resolved | 2022-02-18 | 2022-04-01 | 155308 |
| APO-CETIRIZINE | 20MG | TABLET | Resolved | 2022-02-18 | 2022-04-01 | 155311 |
| APO-IMATINIB | 400MG | TABLET | Resolved | 2022-02-18 | 2022-03-21 | 155314 |
| APO-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2022-02-18 | 2022-05-06 | 155317 |
| APO-TADALAFIL PAH | 20MG | TABLET | Resolved | 2022-02-18 | 2022-04-18 | 155321 |
| APO-TADALAFIL | 20MG | TABLET | Resolved | 2022-02-18 | 2022-04-08 | 155324 |
| APO-NAPROXEN | 500MG | TABLET | Resolved | 2022-02-22 | 2022-03-11 | 155362 |
| APO-TRYPTOPHAN | 500MG | CAPSULE | Resolved | 2022-02-22 | 2022-03-09 | 155365 |
| TRI-CIRA LO 21 | 0.025MG 0.25MG 0.025MG 0.215MG 0.025MG 0.18MG | TABLET | Resolved | 2022-02-22 | 2022-03-07 | 155371 |
| APO-TELMISARTAN-AMLODIPINE | 5MG 80MG | TABLET | Actual shortage | 2022-02-23 | 2022-09-14 | 155482 |
| APO-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2022-02-25 | 2022-03-29 | 155597 |
| APO-ATOMOXETINE | 60MG | CAPSULE | Resolved | 2022-02-25 | 2022-04-01 | 155600 |
| APO-DIVALPROEX | 250MG | TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) | Resolved | 2022-02-25 | 2022-03-24 | 155603 |
| APO-PRAVASTATIN | 10MG | TABLET | Resolved | 2022-02-25 | 2022-03-25 | 155606 |
| APO-PRAVASTATIN | 10MG | TABLET | Resolved | 2022-02-25 | 2022-03-28 | 155609 |
| APO-ABIRATERONE FILM COATED TABLETS | 500MG | TABLET | Resolved | 2022-03-04 | 2022-05-19 | 156030 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-AMOXI SUGAR FREE | 250MG | POWDER FOR SUSPENSION | Discontinued | 2020-06-22 | 2020-06-22 | 118526 |
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 119950 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2021-06-25 | 2021-06-25 | 141546 |
| APO-PINDOL TAB 5MG | 5MG | TABLET | Discontinued | 2022-02-09 | 2022-02-10 | 154568 |
| APO-PINDOL TAB 10MG | 10MG | TABLET | Discontinued | 2022-02-09 | 2022-02-10 | 154571 |
| APO-PINDOL TAB 15MG | 15MG | TABLET | Discontinued | 2022-02-09 | 2022-12-09 | 154574 |
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| APO-BICALUTAMIDE | 50MG | TABLET | Discontinued | 2022-03-25 | 2022-05-13 | 157376 |
| APO-CLOBETASOL SPRAY | 0.05% | SPRAY | Discontinued | 2022-09-06 | 2022-09-06 | 168648 |
| APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE | 300MG 150MG 300MG | TABLET | Discontinued | 2022-12-12 | 2022-12-12 | 177953 |
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
| APO-CARVEDILOL | 12.5MG | TABLET | To be discontinued | 2024-01-26 | 2024-04-01 | 217493 |
| APO-CARVEDILOL | 3.125MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217496 |
| APO-CARVEDILOL | 6.25MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217499 |
| APO-CARVEDILOL | 25MG | TABLET | Discontinued | 2024-01-26 | 2024-01-27 | 217504 |